CareDx, Inc (CDNA)
Automate Your Wheel Strategy on CDNA
With Tiblio's Option Bot, you can configure your own wheel strategy including CDNA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CDNA
- Rev/Share 6.2686
- Book/Share 6.8645
- PB 2.4124
- Debt/Equity 0.0798
- CurrentRatio 4.1067
- ROIC 0.1155
- MktCap 922069080.0
- FreeCF/Share 0.4544
- PFCF 36.7197
- PE 15.5492
- Debt/Assets 0.0618
- DivYield 0
- ROE 0.1817
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 1
- P/B Score 2
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CDNA | Wells Fargo | Underweight | Equal Weight | $28 | $24 | Jan. 15, 2025 |
| Initiation | CDNA | Wells Fargo | -- | Underweight | -- | $28 | Aug. 28, 2024 |
| Upgrade | CDNA | BTIG Research | Neutral | Buy | -- | $40 | Aug. 19, 2024 |
News
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Published: May 22, 2025 by: Business Wire
Sentiment: Neutral
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for potential breaches of fiduciary duties and violations of the federal securities laws. What is Johnson Fistel Investigating? Between April 30, 2020 and February 24, 2022, certain CareDx insiders caused the company to issue false and misleading public statements regarding its compliance with health.
Read More
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Published: May 21, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, May 21, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for potential breaches of fiduciary duties and violations of the federal securities laws.
Read More
CareDx, Inc (CDNA) Q4 2024 Earnings Call Transcript
Published: February 26, 2025 by: Seeking Alpha
Sentiment: Neutral
CareDx, Inc (NASDAQ:CDNA ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Caroline Corner - Investor Relations John Hanna - President and Chief Executive Officer Abhishek Jain - Chief Financial Officer Conference Call Participants Mark Massaro - BTIG Bill Bonello - Craig-Hallum Andrew Cooper - Raymond James Mason Carrico - Stephens Eduardo Martinez - H.C. Wainwright Thomas DeBourcy - Nephron Research Operator Good afternoon, everyone.
Read More
CareDx (CDNA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for CareDx (CDNA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders
Published: February 21, 2025 by: Business Wire
Sentiment: Neutral
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, LLP, a leading stockholder rights law firm, has initiated an investigation into the board members and executive officers of CareDx, Inc. (NASDAQ: CDNA) for potential breaches of fiduciary duties and violations of the federal securities laws. What is Johnson Fistel Investigating? Between April 30, 2020 and February 24, 2022, certain CareDX insiders allegedly caused the company to issue false and misleading public statements regarding its compliance wit.
Read More
CareDx (CDNA) Soars 11.2%: Is Further Upside Left in the Stock?
Published: February 11, 2025 by: Zacks Investment Research
Sentiment: Positive
CareDx (CDNA) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Read More
Final Trades: NRG Energy, MP Materials, CareDx and Applovin
Published: February 10, 2025 by: CNBC Television
Sentiment: Neutral
The Investment Committee give you their top stocks to watch for the second half.
Read More
About CareDx, Inc (CDNA)
- IPO Date 2014-07-17
- Website https://www.caredx.com
- Industry Medical - Diagnostics & Research
- CEO Mr. John Walter Hanna Jr.
- Employees 644